Vaginal cancer

Related records

Broader conditions (16)

• Cancer
• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Female reproductive organ cancer
• Female reproductive system disorder
• Female reproductive system neoplasm
• Human disease
• Neoplasm
• Neoplastic disease or syndrome
• Reproductive system cancer
• Reproductive system disorder
• Reproductive system neoplasm
• Vaginal disorder
• Vaginal neoplasm

Narrower conditions (16)

• Adult vagina botryoid embryonal rhabdomyosarcoma
• Botryoid-type embryonal rhabdomyosarcoma of the vagina
• Childhood vagina botryoid rhabdomyosarcoma
• Endometrioid stromal sarcoma of the vagina
• Malignant vaginal mixed epithelial and mesenchymal neoplasm
• Vagina leiomyosarcoma
• Vagina sarcoma
• Vaginal adenocarcinoma
• Vaginal adenoid cystic carcinoma
• Vaginal adenosarcoma
• Vaginal carcinoma
• Vaginal carcinosarcoma
• Vaginal germ cell malignant tumor
• Vaginal rhabdomyosarcoma
• Vaginal squamous cell carcinoma
• Vaginal yolk sac tumor

Trials (163)

• 3D Printed Custom Applicators for HDR BT (DISCO)
• A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
• A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
• A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
• A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
• A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
• A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
• A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
• A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
• A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
• A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
• A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
• A Survivorship Care Plan for Gynaecological Cancer Patients
• A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
• Agnostic Therapy in Rare Solid Tumors
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
• ASk Questions in GYnecologic Oncology (ASQ-GYO)
• Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study

Drugs in development (34)

• Adavosertib Phase 1
• Aldesleukin Phase 2
• Atezolizumab Phase 1
• Becotatug vedotin Phase 2
• Bintrafusp alfa Phase 1
• Bortezomib Phase 2
• Carboplatin Phase 1
• Cisplatin Phase 3
• Cyclophosphamide Phase 2
• Daratumumab Phase 1
• Disitamab vedotin Phase 2
• Docetaxel Phase 1
• Doxorubicin Phase 1
• Durvalumab Phase 1
• Edodekin alfa Phase 1
• Entinostat Phase 1
• Fludarabine Phase 2
• Human papillomavirus, L1 protein virus like particles Phase 2
• Imiquimod Phase 2
• Immunocytokine nhs-IL12 Phase 1